LPH-5 safety study in healthy volunteers
This first-in-human study tests an investigational drug called LPH-5 in healthy volunteers to see how safe it is and how the body processes it. If you’re generally healthy and meet the few restrictions, you may be able to help doctors learn more about this potential new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good overall health, with no major medical problems.
- No history of a serious illness that could flare up during the trial.
- If you use marijuana or cannabis, you cannot use it more than 3 times a month, and your usage must be stable (no big changes in the 3 weeks before screening).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests a new medicine called LH-001 in healthy volunteers to see if it is safe. You will receive either the medicine or a placebo (a dummy pill) and stay overnight for monitoring.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.